Subscribe rss-microbe
Home Public Affairs Report
Public Affairs Report
ASM Participates in FDA Meeting Print E-mail

On 21 October, staff from the Food and Drug Administration's (FDA) Office of In Vitro Devices met with staff from various clinical laboratory organizations and professional societies, including ASM, for the FDA/Professional Society Roundtable Meeting.

 
Letter to Congress on NIH FY 2011 Appropriation Print E-mail

 A letter was sent in October from medical research organizations, including ASM, asking Congress to approve the fiscal year (FY) 2011 appropriation for the Department of Health and Human Services and to support the $1 billion increase for the National Institutes of Health proposed in the President's budget request to Congress.

 
ASM Presentation on Code of Ethics to NSABB Print E-mail

Ronald Atlas, cochair of the ASM Public and Scientific Affairs Board Biodefense Committee, made a presentation on codes of conduct and dual use research of concern (DURC) on 20 October to the National Science Advisory Board on Biosecurity (NSABB).

 
ASM Cosigns Letters Regarding Laboratory Developed Tests Print E-mail

The ASM signed onto two coalition letters to the Food and Drug Administration (FDA) regarding the possible regulation of Laboratory Developed Tests (LDTs).

 
ASM Represented at National Laboratory Response Network Meeting Print E-mail

Alice Weissfeld, member of the PSAB Committee on Professional Affairs, represented ASM at the National Laboratory Response Network (LRN) meeting in San Diego, Calif., 13-15 October.

 
ASM Attends CCCLW Meeting Print E-mail

Vickie Baselski, chair of the ASM Public and Scientific Affairs Board Committee on Professional Affairs, attended a meeting of the Coordinating Committee for the Clinical Laboratory Workforce (CCCLW) on 13 September.